The 69 National Cancer Institute-designated Cancer Centers are premier academic institutions that place significant value on research integrity and an ethic that rigorous evidence should guide patient care and define expectations. Recent patient-focused advertising has strayed from these values, obscuring valid reasons for seeking care at these centres.
This is a preview of subscription content, log in via an institution to check access.
References
Vater, L. B., Donohue, J. M., Park, S. Y. & Schenker, Y. Trends in cancer-center spending on advertising in the United States, 2005 to 2014. JAMA Intern. Med. 176, 1214–1216 (2016).
Bower, H. et al. Life expectancy of patients with chronic myeloid leukemia approaches the life expectancy of the general population. J. Clin. Oncol. 34, 2851–2857 (2016).
Reck, M. et al. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer. N. Eng. J. Med. 375, 1823–1833 (2016).
Fojo, T., Mailankody, S. & Lo, A. Unintended consequences of expensive cancer therapeutics — the pursuit of marginal indications and a me-too mentality that stifles innovation and creativity. The John Conley Lecture. JAMA Otolarynogol. Head Neck Surg. 140, 1225–1236 (2014).
Niraula, S. et al. Risk of incremental toxicities and associated costs of new anticancer drugs: a meta-analysis. J. Clin. Oncol. 32, 3634–3642 (2014).
Garrido-Laguna, I. & Hidalgo, M. Pancreatic cancer: from state-of-the-art treatments to promising novel therapies. Nat. Rev. Clin. Oncol. 12, 319–334 (2015).
Larson, R. J., Schwartz, L. M., Woloshin, S. & Welch, H. G. Advertising by academic medical centers. Arch. Intern. Med. 165, 645–651 (2005).
Society for Healthcare Strategy & Market Development of the American Hospital Association. SHSMD advisory: principles and practices for marketing communications in hospitals and health systems. WHA http://www.wha.org/data/sites/1/pubArchive/news_releases/marketingcommunicationsadvisory.pdf (2010).
Prasad, V. & Vandross, A. Characteristics of exceptional or super responders to cancer drugs. Mayo Clin. Proc. 90, 1639–1649 (2015).
Gooiker, G. A. et al. Systematic review and meta-analysis of the volume-outcome relationship in pancreatic surgery. Br. J. Surg. 98, 485–494 (2011).
Schwartz, L. A. & Woloshin, S. Cancer center advertising — where hope meets hype. JAMA Intern. Med. 176, 1068–1070 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Rubenson, D., Kapp, D. Getting real about NCI-designated Cancer Center advertising. Nat Rev Clin Oncol 14, 195–196 (2017). https://doi.org/10.1038/nrclinonc.2017.28
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrclinonc.2017.28
- Springer Nature Limited
This article is cited by
-
Online advertising and marketing claims by providers of proton beam therapy: are they guideline-based?
Radiation Oncology (2018)